UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus

Hepatology (Baltimore, Md.), 1998-10, Vol.28 (4), p.1134-1146

1998

Volltextzugriff (PDF)

Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy

Journal of viral hepatitis, 2015-06, Vol.22 (6), p.561-570

2015

Volltextzugriff (PDF)

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

Journal of viral hepatitis, 2005-01, Vol.12 (1), p.67-73

2005

Volltextzugriff (PDF)

Cross-Resistance Testing of Antihepadnaviral Compounds Using Novel Recombinant Baculoviruses Which Encode Drug-Resistant Strains of Hepatitis B Virus

Antimicrobial Agents and Chemotherapy, 2001-06, Vol.45 (6), p.1705-1713

2001

Volltextzugriff (PDF)

Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future Investigation

Antiviral Chemistry and Chemotherapy, 2001-01, Vol.12 (1), p.1-35

2001

Volltextzugriff (PDF)

Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNA

Antimicrobial Agents and Chemotherapy, 1999-08, Vol.43 (8), p.2017-2026

1999

Volltextzugriff (PDF)

Transient Disruption of Intercellular Junctions Enables Baculovirus Entry into Nondividing Hepatocytes

Journal of Virology, 2001-10, Vol.75 (20), p.9857-9871

2001

Volltextzugriff (PDF)

Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus

Antimicrobial Agents and Chemotherapy, 2006-07, Vol.50 (7), p.2471-2477

2006

Volltextzugriff (PDF)

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-1758

2004

Volltextzugriff (PDF)

Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma

Immunity (Cambridge, Mass.), 2021-09, Vol.54 (9), p.2117-2132.e7

2021

Volltextzugriff (PDF)

The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

Journal of Virology, 2003-11, Vol.77 (21), p.11833-11841

2003

Volltextzugriff (PDF)

Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro

Antimicrobial Agents and Chemotherapy, 2002-09, Vol.46 (9), p.3057-3060

2002

Volltextzugriff (PDF)

Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease

Bioorganic & medicinal chemistry letters, 2012-04, Vol.22 (7), p.2629-2634

2012

Volltextzugriff (PDF)

Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity

Bioorganic & medicinal chemistry letters, 2012-02, Vol.22 (3), p.1394-1396

2012

Volltextzugriff (PDF)

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

Hepatology (Baltimore, Md.), 2003-07, Vol.38 (1), p.96-103

2003

Volltextzugriff (PDF)

Combinations of Adefovir with Nucleoside Analogs Produce Additive Antiviral Effects against Hepatitis B Virus In Vitro

Antimicrobial Agents and Chemotherapy, 2004-10, Vol.48 (10), p.3702-3710

2004

Volltextzugriff (PDF)

Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine- resistant HBV

Antiviral therapy, 2005-01, Vol.10 (5), p.625-633

2005

Volltextzugriff (PDF)

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

Hepatology (Baltimore, Md.), 2002-08, Vol.36 (2), p.464-473

2002

Volltextzugriff (PDF)

Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes

Hepatology (Baltimore, Md.), 2003-12, Vol.38 (6), p.1410-1418

2003

Volltextzugriff (PDF)

Therapy of chronic hepatitis B: trends and developments

Current opinion in pharmacology, 2008-10, Vol.8 (5), p.532-540

2008

Volltextzugriff (PDF)

In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector

Antiviral research, 2004, Vol.61 (1), p.27-36

2004

Volltextzugriff (PDF)

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro

Hepatology (Baltimore, Md.), 2003, Vol.37 (1), p.27-35

2003

Volltextzugriff (PDF)

Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus

Antiviral research, 2009-08, Vol.83 (2), p.135-142

2009

Volltextzugriff (PDF)

Antiviral Effect of Oral Administration of Tenofovir Disoproxil Fumarate in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection

Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2720-2728

2005

Volltextzugriff (PDF)

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model

Antiviral research, 2004-08, Vol.63 (2), p.115-121

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus

Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy

Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients

Cross-Resistance Testing of Antihepadnaviral Compounds Using Novel Recombinant Baculoviruses Which Encode Drug-Resistant Strains of Hepatitis B Virus

Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future Investigation

Use of the Hepatitis B Virus Recombinant Baculovirus-HepG2 System to Study the Effects of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine on Replication of Hepatitis B Virus and Accumulation of Covalently Closed Circular DNA

Transient Disruption of Intercellular Junctions Enables Baculovirus Entry into Nondividing Hepatocytes

Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma

The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro

Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease

Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B

Combinations of Adefovir with Nucleoside Analogs Produce Additive Antiviral Effects against Hepatitis B Virus In Vitro

Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine- resistant HBV

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes

Therapy of chronic hepatitis B: trends and developments

In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro

Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus

Antiviral Effect of Oral Administration of Tenofovir Disoproxil Fumarate in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model

Suchergebnisse filtern